Klotho Therapeutics Patents – Insights & Stats (Updated 2023)

Klotho Therapeutics has a total of 44 patents globally, out of which 6 have been granted. Of these 44 patents, more than 81% patents are active. Japan & South Korea is where Klotho Therapeutics has filed the maximum number of patents, followed by United States of America. Parallelly, the USA seems to be the main focused R&D center of Klotho Therapeutics and is also the origin country of the firm.

Klotho Therapeutics was founded in the year 2016 by James Plante. The company is focused on development and commercialization of recombinant human Klotho proteins to prevent and treat kidney disease and other diseases.

Do read about some of the most popular patents of Klotho Therapeutics which have been covered by us in this article and also you can find Klotho Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Klotho Therapeutics patent portfolio.

How many patents does Klotho Therapeutics have?

Klotho Therapeutics has a total of 44 patents globally. These patents belong to 6 unique patent families. Out of 44 patents, 36 patents are active.

How Many Patents did Klotho Therapeutics File Every Year?

Klotho Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantKlotho Therapeutics Applications FiledKlotho Therapeutics Patents Granted
202231
20218
20201
20191
20189
201720
2016

How many Klotho Therapeutics patents are Alive/Dead?

Worldwide Patents

Klotho Therapeutics Patent Portfolio

How Many Patents did Klotho Therapeutics File in Different Countries?

Klotho Therapeutics Worldwide Patent Filing

Countries in which Klotho Therapeutics Filed Patents

CountryPatents
Japan6
Korea (South)6
United States Of America5
Canada4
Australia4
Europe4
China3
Brazil2
Mexico2

Where are Research Centres of Klotho Therapeutics Patents Located?

The R&D Centres of patents filed by Klotho Therapeutics is in the US.

Most Cited Klotho Therapeutics Patent

US20190169593A1 is the most popular patent in the Klotho Therapeutics portfolio. It has received 9 citations so far from companies like Catalyst Biosciences.

List of Klotho Therapeutics Patents

Klotho Therapeutics PatentsTitle
US20230279006A1Novel Compounds And Methods For Increasing Klotho Gene Expression
US20230278953A1Water Soluble Prodrugs Of Ptba For Use In Hdac Inhibition And Enhancing Renal Recovery Following Acute Kidney Injury
US20210371839A1Products And Methods For Assessing And Increasing Klotho Protein Levels
US20200181224A1Novel Recombinant Klotho Proteins And Compositions And Methods Involving Same
US20190169593A1Products And Methods For Assessing And Increasing Klotho Protein Levels
EP4178560A1Water Soluble Prodrugs Of Ptba For Use In Hdac Inhibition And Enhancing Renal Recovery Following Acute Kidney Injury
EP3720474A4Products And Methods For Assessing And Increasing Klotho Protein Levels
EP3551212A4Novel Recombinant Klotho Proteins And Compositions And Methods Involving The Same
EP3464608A4Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same
CN116478907ATherapeutic Recombinant Klotho Proteins And Compositions And Methods Thereof
CN109996555ANovel Recombinant Klotho Proteins And Compositions And Methods Involving The Same
CN109219663ATherapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same
WO2023283648A1Novel Combinatorial Antitumor Treatment Methods And Related Compositions, Kits, And Systems
AU2017363321B2Novel Recombinant Klotho Proteins And Compositions And Methods Involving The Same
AU2017272349B2Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same
AU2021305330A1Water Soluble Prodrugs Of Ptba For Use In Hdac Inhibition And Enhancing Renal Recovery Following Acute Kidney Injury
AU2018378802A1Products And Methods For Assessing And Increasing Klotho Protein Levels
CA3185103A1Water Soluble Prodrugs Of Ptba For Use In Hdac Inhibition And Enhancing Renal Recovery Following Acute Kidney Injury
CA3101100A1Products And Methods For Assessing And Increasing Klotho Protein Levels
CA3041910A1Novel Recombinant Klotho Proteins And Compositions And Methods Involving The Same
CA3025461A1Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same
JP7290340B2Products And Methods For Assessing And Improving Klotho Protein Levels
JP7244923B2Novel Recombinant Klotho Protein And Compositions Containing Same
JP2023123565ATherapeutic Recombinant Klotho Protein And Compositions And Methods Comprising The Same
JP2023113737A5Products And Methods For Assessing And Improving Klotho Protein Levels
JP2023533986AA Water-Soluble Prodrug Of Ptba For Use In Hdac Inhibition And Promoting Renal Recovery After Acute Kidney Injury
KR102570250B1Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving Them
KR1020230125857ATherapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same
KR1020230093531ANovel Recombinant Klotho Proteins And Compositions And Methods Involving The Same
KR1020230039680AWater-Soluble Prodrug Of Ptba For Use In Inhibiting Hdac And Enhancing Renal Recovery After Acute Kidney Injury
KR1020200095538AProducts And Methods For Assessing And Increasing Klotho Protein Levels
KR1020190088988ANovel Recombinant Klotho Proteins And Compositions And Methods Containing Same
MX404596BTherapeutic Recombinant Klotho Proteins And Compositions And Methods Involving Them.
BR112019010250A2New Recombinant Klotho Proteins And Compositions And Methods Involving Them
MX2019005687ANovel Recombinant Klotho Proteins And Compositions And Methods Involving The Same.
BR112018073909A2Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same
WO2022217255A1Novel Antitumor Compounds And Related Methods Of Manufacture And Use
WO2022178544A1Novel Heterocyclic Compounds And Related Methods Of Manufacture And Use In Hdac Inhibition
WO2022011171A1Novel Compounds And Methods For Increasing Klotho Gene Expression
WO2022011174A1Water Soluble Prodrugs Of Ptba For Use In Hdac Inhibition And Enhancing Renal Recovery Following Acute Kidney Injury
WO2019113373A3Products And Methods For Assessing And Increasing Klotho Protein Levels
WO2018098375A1Novel Recombinant Klotho Proteins And Compositions And Methods Involving The Same
WO2017210607A1Therapeutic Recombinant Klotho Proteins And Compositions And Methods Involving The Same
JP2019526272A5Therapeutic Recombinant Klotho Proteins And Compositions And Methods Containing The Same

What are Klotho Therapeutics’ key innovation segments?

What Technologies are Covered by Klotho Therapeutics?

The chart below distributes patents filed by Klotho Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Klotho Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Klotho Therapeutics’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Klotho Therapeutics?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.